KNW — Know Labs Income Statement
0.000.00%
- $1.28m
- $4.30m
Annual income statement for Know Labs, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | C2022 September 30th | 2023 September 30th | 2024 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.122 | 0 | 4.36 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 0.052 | 0 | — | — | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 7.66 | 10.4 | 16.9 | 14.3 | 15.2 |
Operating Profit | -7.53 | -10.4 | -12.6 | -14.3 | -15.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -13.6 | -25.4 | -20.1 | -15.3 | -16.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -13.6 | -25.4 | -20.1 | -15.3 | -16.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -13.6 | -25.4 | -20.1 | -15.3 | -16.6 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -13.6 | -25.4 | -20.1 | -20.4 | -16.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -23.6 | -34.5 | -19.9 | -16.3 | -7.85 |